Showing results (661-670 of 895) with videos related to
Sort By:
Pageof 90
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogressionGuillaume B E Stewart-Jones, Geraldine Gillespie, Ian M Overton, et al.Human Immunology|October 1, 1987
Functional and biochemical subtypes of the haplotype HLA-DR3 in patients with celiac disease or idiopathic membranous nephropathyS H Sacks, A Bushell, N A Rust, et al.AIDS (London, England)|September 1, 1990
An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitopeD F Nixon, S Huet, J Rothbard, et al.The Journal of Experimental Medicine|April 6, 1999
Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cellsD S Allan, M Colonna, L L Lanier, et al.AIDS Research and Human Retroviruses|December 10, 1996
Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infectionP J Goulder, M Bunce, P Krausa, et al.European Journal of Immunology|December 1, 1995
Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognitionJ S Haurum, L Tan, G Arsequell, et al.Transplantation|January 27, 1997
Weaning of immunosuppression in liver transplant recipientsG V Mazariegos, J Reyes, I R Marino, et al.Gene Therapy|May 28, 2004
Engineering RENTA, a DNA prime-MVA boost HIV vaccine tailored for Eastern and Central AfricaJ P Nkolola, E G-T Wee, E-J Im, et al.Journal of Neurology|April 12, 2007
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, AustraliaI A F van der Mei, A-L Ponsonby, T Dwyer, et al.Nature Communications|August 9, 2023
High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activationBrooke D Huisman, Ning Guan, Timo Rückert, et al.Pageof 90